U.S. Stem Cell, Inc.
USRMDelisted- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001388319
U.S. Stem Cell, Inc. was delisted in 2026; its insiders filed their last Form 4 on Apr 29, 2022; 1 institution reported holding it in 13F filings for Q2 2026, worth $11 in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by U.S. Stem Cell, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for U.S. Stem Cell, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Knutson Gregory | Director | 29,175,000 | Apr 29, 2022 | 0 |
| Murphy William P Jr | Director | 9,352,603Indirect | Jul 23, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.